Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targeting
Abstract Tauopathies are neurodegenerative diseases that typically require postmortem examination for a definitive diagnosis. Detecting neurotoxic tau fragments in cerebrospinal fluid (CSF) and serum provides an opportunity for in vivo diagnosis and disease monitoring. Current assays primarily focus...
Main Authors: | Liara Rizzi, Lea T. Grinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-024-01744-9 |
Similar Items
-
Publisher Correction: Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targeting
by: Liara Rizzi, et al.
Published: (2024-04-01) -
Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model
by: YoungDoo Kim, et al.
Published: (2016-03-01) -
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
by: Elisa Canepa, et al.
Published: (2021-01-01) -
Dual truncation of tau by caspase-2 accelerates its CHIP-mediated degradation
by: Lydia Reinhardt, et al.
Published: (2023-06-01) -
Tau exhibits unique seeding properties in globular glial tauopathy
by: Dah-eun Chloe Chung, et al.
Published: (2019-03-01)